Evidence map›Paper›PMID 41876748›Full record

ArticleApplied microbiology and biotechnology2026

Optimized green zinc oxide/chitosan/amoxicillin nanocomposite against Pseudomonas aeruginosa.

Mohamed M El-Zahed, Yassmein M Radwan, Mohamed I Abou-Dobara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohamed M El-ZahedDepartment of Botany and Microbiology, Faculty of Science, Damietta University, New Damietta, 34517, Egypt. mohamed.marzouq91@du.edu.eg.ORCID http://orcid.org/0000-0003-2694-3720
Yassmein M RadwanDepartment of Botany and Microbiology, Faculty of Science, Damietta University, New Damietta, 34517, Egypt.
Mohamed I Abou-DobaraDepartment of Botany and Microbiology, Faculty of Science, Damietta University, New Damietta, 34517, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant Pseudomonas aeruginosa poses a significant global health threat, highlighting the need for innovative antimicrobial strategies. This study presents the successful synthesis, optimization, and characterization of a novel zinc oxide/chitosan/amoxicillin (ZnO/CS/AMX) nanocomposite aimed at combating P. aeruginosa infections, including the ability to form biofilms. Response surface methodology (RSM) based on the Box-Behnken design (BBD) was used to optimize the production of ZnO NPs using cell-free metabolites of P. aeruginosa. The optimal parameters for biosynthesis of ZnO NPs require a mixing ratio of 1:4 v/v% between the cell-free bacterial metabolites and 30 mM Zn precursor (Zn(NO

Indexed as

Anti-Bacterial AgentsChitosanNanocompositesPseudomonas aeruginosaZinc OxideBiofilmsMicrobial Sensitivity TestsAnti-Bacterial AgentsChitosanZinc OxideAntibiofilmAnti-Pseudomonas aeruginosaNanocompositeRSM optimizationZinc oxide

Identifiers

PMID41876748
PMCPMC13018007

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.